|
|
||||||||
Ann Thorac Surg 2001;72:1523-1527
© 2001 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Royal Hospitals Trust, Belfast, Northern Ireland, United Kingdom
Accepted for publication June 22, 2001.
* Address reprint requests to Mr OKane, Department of Cardiac Surgery, Royal Hospitals Trust, Grosvenor Rd, Belfast, Northern Ireland BT12 6BA, UK
e-mail: hugh{at}doctors.org.uk
Background. This study was conducted to assess the ability of patients receiving heart valve replacements to practice self-managed anticoagulation using a portable coagulometer.
Methods. We carried out a prospective, randomized trial, comparing self-managed anticoagulation with conventional management. Patients practicing self-managed anticoagulation (51 patients) did so at home, measuring their international normalized ratio and then deciding on their dosage of warfarin, while conventionally controlled patients (n = 49) attended hospital clinics or were managed by their family physicians.
Results. We successfully trained 41 of 44 patients who agreed to self-manage their anticoagulant therapy; 34 of the 41 managed their own anticoagulation at home for 2 years. Their control, assessed by a number of tests in range (67.6% versus 58.0%) and time in therapeutic range (76.5% versus 63.8%), was significantly better than that for the group managed conventionally (p < 0.0001). There was no significant difference in mortality or morbidity between the two groups.
Conclusions. Self-managed anticoagulation is a reliable, easily learned method of controlling anticoagulation, and it is suitable for approximately two thirds of patients, with excellent results.
Related Article
Ann. Thorac. Surg. 2001 72: 1527.
This article has been cited by other articles:
![]() |
C Gardiner, I Longair, M A Pescott, H Erwin, J Hills, S J Machin, and H Cohen Self-monitoring of oral anticoagulation: does it work outside trial conditions? J. Clin. Pathol., February 1, 2009; 62(2): 168 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 160S - 198S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Regier, R. Sunderji, L. D. Lynd, K. Gin, and C. A. Marra Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. Can. Med. Assoc. J., June 20, 2006; 174(13): 1847 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van Walraven, A. Jennings, N. Oake, D. Fergusson, and A. J. Forster Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression Chest, May 1, 2006; 129(5): 1155 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S.J. Miller, M. F. Drummond, L. K. Langkilde, J. J.V. McMurray, and M. Ogren Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C41 - C54. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Menendez-Jandula, J. C. Souto, A. Oliver, I. Montserrat, M. Quintana, I. Gich, X. Bonfill, and J. Fontcuberta Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial Ann Intern Med, January 4, 2005; 142(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. O'Kane The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: A meta-analysis J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1143 - 1143. [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. G. Masters, F. D. Rubens, P. J. Bedard, A. L. Pipe, W. G. Goldstein, P. J. Hendry, and T. G. Mesana Late incidence and determinants of stroke after aortic and mitral valve replacement Ann. Thorac. Surg., July 1, 2004; 78(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vink, R. A. Kraaijenhagen, B. A. Hutten, R. B. A. van den Brink, B. A. de Mol, H. R. Buller, and M. Levi The optimal intensity of vitamin k antagonists in patients with mechanical heart valves: A meta-analysis J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Christensen, V. E. Hjortdal, and J. M. Hasenkam Reply to Sidhu and MacGowan Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 669 - 669. [Full Text] [PDF] |
||||
![]() |
P. Sidhu and S. W. MacGowan Self-managed anticoagulation is safe and effective Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 668 - 668. [Full Text] [PDF] |
||||
![]() |
R L Howard, A J Avery, P D Howard, and M Partridge Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study Qual. Saf. Health Care, August 1, 2003; 12(4): 280 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Emery, G. J. Van Nooten, and P. J. Tesar The initial experience with the ATS Medical mechanical cardiac valve prosthesis Ann. Thorac. Surg., February 1, 2003; 75(2): 444 - 452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |